Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Catapano, F. Mannucci, G. Mirarchi, C. Carli, R. Prediletto (Pisa, Italy). Renewed role of nitrogen slope of phase III in chronic obstructive pulmonary disease (COPD). Eur Respir J 2008; 32: Suppl. 52, 4639

Member's Comments

No comment yet.

Related content which might interest you: The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 608s Year: 2004 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Model of staged development chronic obstructive pulmonary disease (COPD) in rats Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Chronic obstructive pulmonary disease (COPD) – patient‘s perspective Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007 Accelerated ageing and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 The audit-intervention-reaudit cycle can improve diagnostic standards for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Characteristics of blood ammonia response to exercise in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 608s Year: 2006 The role of CD4/CD8 ratio in development of chronic obstructive pulmonary disease (COPD) among smokers Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002 Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Regional ventilatory defects in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006 The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005 Stress reaction and attention concentration in free time in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 309s Year: 2005 Exercise capacity predicts survival in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 488s Year: 2001